Channing Global Advisors, LLC Astrazeneca PLC Transaction History
Channing Global Advisors, LLC
- $138 Million
- Q4 2024
A detailed history of Channing Global Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Channing Global Advisors, LLC holds 10,231 shares of AZN stock, worth $761,697. This represents 0.49% of its overall portfolio holdings.
Number of Shares
10,231
Previous 5,864
74.47%
Holding current value
$761,697
Previous $456,000
46.93%
% of portfolio
0.49%
Previous 0.43%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,341Shares Held
477MCall Options Held
5.39MPut Options Held
3.29M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.68 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.05 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.79 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.76 Billion0.46% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.45 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $231B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...